Vasoactive Intestinal Peptide (Vip) (Middle Region) Peptide
-
- Target See all Vip products
- Vip (Vasoactive Intestinal Peptide (Vip))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VPVKRHSDAV FTDNYTRLRK QMAVKKYLNS ILNGKRSSEG ESPDFPEELE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-VIP Antibody(ARP45465_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Vip (Vasoactive Intestinal Peptide (Vip))
- Background
-
The protein encoded by this gene belongs to the glucagon family. It stimulates myocardial contractility, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.
Alias Symbols: MGC13587, PHM27
Protein Interaction Partner: MEOX2,MME,PRICKLE1,UBQLN4,VIPR1,VIPR2,MEOX2,MEP1A
Protein Size: 170 - Molecular Weight
- 3 kDa
- Gene ID
- 7432
- NCBI Accession
- NM_003381, NP_003372
- UniProt
- P01282
-